Clinical Trial Update: Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating durvalumab plus tremelimumab in combination with chemotherapy for HIV-infected patients with non-small cell lung cancer; recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: Georgetown University | Conditions: Carcinoma, Non-Small Cell Lung | Phase 2 | Status: RECRUITING